Since inception of commercial and defense-related air travel, there has been constant increase in the number of people travelling internationally. In addition, globalization has fueled the idea of global village with higher rate of people travelling to different countries for travel, work purpose, and formal trade relations. A common complaint associated with frequent air travel is “jet lag.” It results from body’s inability to readjust to rapid changes in time and external macroenvironment. This results in increased fatigue, decreased energy levels, and distorted body metabolism. Over the years, various advanced therapeutics have been deployed as portable treatment options for jet lag, including intermittent sleeping patterns and use of melatonin.
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the time zone change syndrome market.
Top Impacting Factors
- Two-fold rise in air travel each year disrupts sleep patterns, body metabolism, and gastro intestinal tract, resulting in alterations of body clock, also known as circadian rhythms. This, in turn, has paved way for easy and quick treatment therapeutics to treat jet lags.
- Rise in global trade, supply chain efficiencies, globalized migrations into new places for work purposes, and the growing idea of one globalized village resulting in frequent air travels across continents and regions drive the demand for jetlag treatment therapeutics.
- Growing advantages of deploying easy-to-use, portable wearable technologies to monitor cardiovascular patterns especially in regions with high disposable income and better skilled personnel support the growth of the market.
- However, cases of drug addictions attached with the use of these advanced therapeutics to treat jet lags—such as addictions attached to melatonin are the most frequent ones—hamper the market growth.
- Additionally, less purchasing power parity and low awareness regarding new age portable wearable technologies in underdeveloped nations might hamper market penetration into these areas.
Key Market Trends
- North America is anticipated to gain significant traction, owing increased use of melatonin as a viable solution against time zone change treatment therapy. In addition, the region holds highest number of regional and global manufacturers, thus providing them with an array of frequent product trials.
- Neuroon is a revolutionary and utterly successful device that was established as a possible countermeasure against jet lags. The device incorporates advanced brain wave and pulse measurement mechanisms to improve sleep patterns. It further uses biometric sensors to study person’s sleep architecture and offer sleep optimization routine.
- Recently, light therapy has come under intense consideration as a viable jet lag treatment alternative. The mechanism is employed at night to speed up brain’s adjustments toward time changes with the help of a technique known as “biological hacking.”
- Use of hypnotics too has been proposed to balance the tradeoff between sleep cycle and time changes.
- Triazolam, an advanced therapeutic drug, has been see to block jet lag effects in early clinical trials, thus realigning the circadian cycles. However, the efficacy of the drug at a larger level is still highly questionable.
- NASA studies have proposed the idea of regular intermittent napping as a countermeasure to time zone change syndrome. The technique has shown results with NASA’s Hubble aircraft with aircrew taking short naps in between to balance out their circadian cycles and thus is being further proposed for commercial air travel.
Key Benefits of the Report
- This study presents the analytical depiction of the time zone change syndrome industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the time zone change syndrome market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in Time Zone Change Syndrome Report
- Which are the leading players active in the time zone change syndrome market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the time zone change syndrome market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 in the industry?
- What is time zone change syndrome?
- What is the time zone change syndrome market prediction in the future?
- What are the current trends and predicted trends?
Time Zone Change Syndrome Market, by Product Report Highlights
| Aspects | Details |
 By Product |
|
 By Distributional Channel |
|
 By Region |
|
 Key Market Players | Teva, Nature’s Bounty, Pfizer Inc., Homeocan, Purdue Pharma L.P., Boiron, NOW Foods, Clinigen Group, Eisai Co., Ltd., Miers Laboratories, ALEXZA, Clinigen Group plc., Jazz Pharmaceuticals, Inc., Genexa, Otsuka, Vanda Pharma, Mylan, Jamieson Laboratories Ltd, Pharma (Pharmavite) |
Loading Table Of Content...
